Answers are grounded in this paper and cite their sources.
INTRODUCTION Altered eating behaviour is a hallmark feature of behavioural variant frontotemporal dementia (bvFTD). These changes may represent a compensatory response to an underlying metabolic disturbance. However, whether increased lipid availability restores metabolic homeostasis or instead accelerates disease progression remains unknown. TDP-43 proteinopathies, which account for approximately half of FTD cases, are associated with alterations in lipid metabolism, providing a mechanistic framework to investigate the cerebral response to lipid overload. METHODS We combined clinical observations in patients with bvFTD with mechanistic studies in the physiological TardbpM323K/M323K knock-in mouse model to determine how TDP-43 dysfunction modifies the response to chronic lipid excess. RESULTS In the bvFTD cohort, elevated cholesterol and triglycerides were associated with poorer cognitive performance, while mutant mice fed a lifelong high-fat diet showed worse cognitive impairment. Multi-omics analyses of the frontal cortex revealed maladaptive metabolic rewiring characterized by impaired mitochondrial and cholesterol metabolism, lipid accumulation, and widespread remodelling of TDP-43-dependent RNA processing. These alterations affected synaptic function and neuronal communication and were accompanied by reduced cerebral glucose utilization measured by 18F-FDG PET, neurotransmitter imbalance and enhanced neuroinflammation. DISCUSSION Increased lipid availability fails to compensate for TDP-43-associated metabolic dysfunction and instead promotes maladaptive molecular and functional responses. These findings identify impaired metabolic resilience as feature of TDP-43-mediated neurodegeneration and suggest that altered eating behaviour in bvFTD may represent an unsuccessful attempt to counteract an underlying metabolic deficit rather than a purely behavioural symptom. Thus, the biological context may determine whether increased energy intake is beneficial or detrimental during neurodegeneration.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: